NTRR Forms New Cannabis Joint Venture With Colorado Plant Specialists
Neutra Corp. (NTRR), a premiere distributor of indoor agricultural solutions, announced today that the company formed a new joint venture with Colorado plant specialists Green Mountain Plant Health, LLC, to supply a suite of horticultural products that can help control—and potentially eliminate—plant contaminates such as molds without the use of harsh chemicals in indoor cannabis grows.
The new joint venture is a major milestone for NTRR as the company works to become a major service and technology provider in the fastest-growing industry in the country: cannabis. With the help of another joint venture partner, Surface to Air Solutions (S2O2), NTRR is offering cannabis growers and other businesses new technologies designed to reduce or eliminate the industry’s reliance upon pesticides to produce healthy crops. The suite of horticultural products, which includes a plant stimulant, an air-scrubber and a self-cleaning hard surface treatment, keeps plants and surfaces clean and prevent the buildup of mold, powdery mildew, botrytis, and mites – allowing for healthy plants without the use of pesticides and fungicides.
Thanks to the new joint venture agreement signed this week, Green Mountain Plant Health will begin marketing this product suite to clients’ growing facilities across Colorado—the nation’s leading cannabis market.
“Green Mountain makes an ideal partner for this venture because they serve clients that are very eager for the kinds of innovations that we’re marketing,” said NTRR CEO Chris Brown. “Together, we believe we can really revolutionize plant care in this historic, emerging industry nationwide.”
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
View source version on businesswire.com:https://www.businesswire.com/news/home/20151014005586/en/
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com